| Year |
Citation |
Score |
| 2017 |
Parker CG, Kuttruff CA, Galmozzi A, Jørgensen L, Yeh CH, Hermanson DJ, Wang Y, Artola M, McKerrall SJ, Josyln CM, Nørremark B, Dünstl G, Felding J, Saez E, Baran PS, et al. Chemical Proteomics Identifies SLC25A20 as a Functional Target of the Ingenol Class of Actinic Keratosis Drugs. Acs Central Science. 3: 1276-1285. PMID 29296668 DOI: 10.1021/Acscentsci.7B00420 |
0.421 |
|
| 2015 |
McKerrall SJ, Jørgensen L, Kuttruff CA, Ungeheuer F, Baran PS. Correction to "Development of a Concise Synthesis of (+)-Ingenol". Journal of the American Chemical Society. PMID 26535919 DOI: 10.1021/Jacs.5B11112 |
0.496 |
|
| 2014 |
McKerrall SJ, Jørgensen L, Kuttruff CA, Ungeheuer F, Baran PS. Development of a concise synthesis of (+)-ingenol. Journal of the American Chemical Society. 136: 5799-810. PMID 24712341 DOI: 10.1021/Ja501881P |
0.508 |
|
| 2014 |
Joergensen L, McKerrall SJ, Kuttruff CA, Ungeheuer F, Felding J, Baran PS. ChemInform Abstract: 14-Step Synthesis of (+)-Ingenol from (+)-3-Carene. Cheminform. 45: no-no. DOI: 10.1002/chin.201403209 |
0.465 |
|
| 2014 |
McKerrall S, Baran P. More Dead Ends and Detours. En Route to Successful Total Synthesis. By Miguel A. Sierra, Maria C. de la Torre, and Fernando P. Cossío. Angewandte Chemie International Edition. 53: 1740-1740. DOI: 10.1002/Anie.201309008 |
0.405 |
|
| 2013 |
Jørgensen L, McKerrall SJ, Kuttruff CA, Ungeheuer F, Felding J, Baran PS. 14-step synthesis of (+)-ingenol from (+)-3-carene. Science (New York, N.Y.). 341: 878-82. PMID 23907534 DOI: 10.1126/Science.1241606 |
0.521 |
|
| 2013 |
Miranda MS, Da Silva JCGE, Hon C, McKerrall SJ, Liebman JF. The structure and energetics of pyrrolidinones, tetrahydrofuranones, piperidinones, and tetrahydropyranones: A computational study Structural Chemistry. 24: 1829-1839. DOI: 10.1007/S11224-013-0237-X |
0.37 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Chernov-Rogan T, Li T, Lu G, Verschoof H, Khakh K, Jones SW, Beresini MH, Liu C, Ortwine DF, McKerrall SJ, Hackos DH, Sutherlin D, Cohen CJ, Chen J. Mechanism-specific assay design facilitates the discovery of Nav1.7-selective inhibitors. Proceedings of the National Academy of Sciences of the United States of America. PMID 29311306 DOI: 10.1073/Pnas.1713701115 |
0.287 |
|
| 2019 |
McKerrall SJ, Nguyen T, Lai KW, Bergeron P, Deng L, DiPasquale A, Chang JH, Chen J, Chernov-Rogan T, Hackos DH, Maher J, Ortwine DF, Pang J, Payandeh J, Proctor WR, et al. Structure- and ligand-based discovery of chromane arylsulfonamide Na1.7 inhibitors for the treatment of chronic pain. Journal of Medicinal Chemistry. PMID 30943032 DOI: 10.1021/Acs.Jmedchem.9B00141 |
0.273 |
|
| 2018 |
McKerrall SJ, Sutherlin DP. Na1.7 inhibitors for the treatment of chronic pain. Bioorganic & Medicinal Chemistry Letters. PMID 30139550 DOI: 10.1016/J.Bmcl.2018.08.007 |
0.234 |
|
| 2021 |
Safina BS, McKerrall SJ, Sun S, Chen CA, Chowdhury S, Jia Q, Li J, Zenova AY, Andrez JC, Bankar G, Bergeron P, Chang JH, Chang E, Chen J, Dean R, et al. Discovery of Acyl-sulfonamide Na1.7 Inhibitors GDC-0276 and GDC-0310. Journal of Medicinal Chemistry. PMID 33682420 DOI: 10.1021/acs.jmedchem.1c00049 |
0.2 |
|
| 2023 |
Kschonsak M, Jao CC, Arthur CP, Rohou AL, Bergeron P, Ortwine DF, McKerrall SJ, Hackos DH, Deng L, Chen J, Li T, Dragovich PS, Volgraf M, Wright MR, Payandeh J, et al. Cryo-EM reveals an unprecedented binding site for Na1.7 inhibitors enabling rational design of potent hybrid inhibitors. Elife. 12. PMID 36975198 DOI: 10.7554/eLife.84151 |
0.162 |
|
| 2017 |
Chernov-Rogan T, Li T, Verschoof H, Khakh K, Jones S, McKerrall S, Hackos DH, Sutherlin D, Cohen CJ, Chen J. A Novel Membrane Potential Assay to Identify Nav1.7-Selective Blockers Biophysical Journal. 112: 333a. DOI: 10.1016/j.bpj.2016.11.1801 |
0.076 |
|
| Hide low-probability matches. |